Weight Loss Injections and Travel Insurance: The Facts

The misconception: 'It's just a diet injection, I don't need to declare it'

A common assumption is that weight loss injections sit in the same category as vitamins or slimming aids and can be quietly omitted from a travel insurance application. That assumption is wrong, and it can be costly. Mounjaro (tirzepatide) and Wegovy (semaglutide) are Prescription-Only Medicines, regulated by the MHRA, assessed individually by a prescriber, and taken for clinical reasons. Insurers' medical declaration processes exist to understand your complete health picture, and that picture includes any POM you are using.

Equally, the reason you were prescribed the medicine matters. GLP-1 medicines are licensed for weight management in adults where weight is a health condition, and sometimes alongside conditions such as type 2 diabetes or high blood pressure, and if you are using an injection for insulin resistance as well as weight loss, that metabolic context is equally relevant to declare. Insurers are interested in those underlying conditions as much as in the medication itself. Declaring the medicine without disclosing the associated conditions would leave your policy on shaky ground. The NHS's patient information for tirzepatide sets out clearly what this class of medicine is used for, that context is useful when you are completing a declaration form.

The honest route is always the safest one: declare the medicine, declare any conditions it relates to, and let the insurer rate the risk accurately. Most people find this is entirely routine. If you are unsure what a specific insurer's form is really asking, their medical screening line can clarify, and reading up on how weight loss injections affect insurance cover beforehand will help you ask the right questions.

What insurers actually want to know about your prescription

Travel insurers typically ask whether you have been prescribed any medicine in the past twelve months and whether that medicine is for a diagnosed condition. For most people on Mounjaro or Wegovy, the relevant conditions to declare are those that prompted the prescription, obesity classified as a health condition, type 2 diabetes, hypertension, or similar. The medicine itself (tirzepatide, semaglutide) is rarely listed by name on insurer screening tools at this early stage of mainstream adoption, which is why it helps to know what the active ingredient is and what it treats.

If you are unsure which conditions to list, your prescriber is the right person to ask. At nume, a real clinician reviews every consultation and every repeat order, so there is a clear clinical record of why you were prescribed treatment. That record is yours, you can refer to it when completing insurance forms. Knowing the background to your prescription puts you in a much stronger position than guessing. You may also find it useful to read through the answers to common questions about treatment as a starting point before speaking with your insurer.

One practical note: if you are paying privately for treatment, it will not appear automatically in your NHS Summary Care Record. Some insurers accept a letter from your prescriber confirming your treatment; others rely entirely on your self-declaration. Either way, the information exists and is accessible to you.

Travelling with the pens: storage, customs and the practicalities

Declaring the medicine to an insurer and actually travelling with it are two separate things, both of which need thought. The injection forms of Mounjaro and Wegovy require refrigeration between 2°C and 8°C; there is a limited window during which they can be kept at room temperature without refrigerating, but the exact duration is product-specific and printed in the Patient Information Leaflet inside the box. That leaflet travels with you. Do not rely on a third party's summary, the leaflet is your reference for storage during a trip.

Practically, this means planning for refrigerated storage at your destination (most hotels will accommodate a medical request), keeping the pen in a cool bag during transit, and not checking it in a hold where temperatures are unpredictable. Some patients use insulated medical-grade pouches designed for insulin; the same principles apply here. If you are concerned about storage across a long-haul itinerary, this is worth discussing with your prescriber before you travel, our guide on travelling with weight loss injections covers the logistics in more detail.

For customs, carry the original pen in its packaging, with your prescription documentation. Most countries accept UK-prescribed medicines for personal use without issue, but it is worth checking the rules of your destination country for any controlled-substance restrictions. The NHS England guidance on weight management injections provides a useful reference point for understanding how these medicines are classified officially.

One more thing: counterfeit pens and supply abroad

Some people ask whether they can simply buy more pens at their destination if they run out. The honest answer is: it depends entirely on the country, and in many cases the answer is no, or not safely. Supply of GLP-1 medicines has been strained globally, and the MHRA has documented multiple cases of counterfeit pens entering the UK market through unverified online sellers. The same risk exists in popular holiday destinations, and anyone with a neurological condition should also read up on how MS and weight loss injections interact before sourcing medicine abroad. The safest approach is to bring enough supply for your trip, accounting for any delays on your return.

If you are thinking about the cost of building up a larger supply before travel, you may also want to understand what is currently known about weight loss injections and cancer as part of making a fully informed decision about your treatment. When your next supply is due, getting a clinical review and repeat prescription through a GPhC-registered pharmacy means everything is sourced through the licensed UK supply chain. At nume, each repeat goes through a fresh clinical review before anything is dispensed. Your treatment arrives tracked with DPD, in plain, unmarked packaging, practical and discreet, especially before a trip when you need certainty about what is coming and when.

If you have questions about your specific situation before travelling, our support team is available seven days a week. And if you have not yet started treatment but are considering it, a free consultation with our prescribers is the first step.